✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹11 Cr.
P/E
25.89
  • Unjha Formulations
  • Decipher Labs
  • Venmax Drugs&Pharma
FAQs on Unjha Formulations Ltd. Shareprice

Unjha Formulations has given lower returns compared to its competitors.
Unjha Formulations has grown at ~15.23% over the last 6yrs while peers have grown at a median rate of 15.62%

Unjha Formulations is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Unjha Formulations is 25.89, while 3 year average PE is 23.37.
Also latest EV/EBITDA of Unjha Formulations is 16.82 while 3yr average is 24.45.

Growth Table
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Balance Sheet
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Cash Flow
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Quarterly Results
  • Unjha Formulations Ltd.
  • Decipher Labs
  • Venmax Drugs&Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Unjha Formulations Ltd. Financials

Balance sheet of Unjha Formulations is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Unjha Formulations is increasing.
Latest net debt of Unjha Formulations is -₹0.64 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹1.75 Crs.

The profit is oscillating.
The profit of Unjha Formulations is ₹0.28 Crs for Mar 2024, ₹0.28 Crs for Mar 2023 and ₹0.25 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Unjha Formulations latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech